Some market insights on sternal closure systems
Report Overview
The global sternal closure systems market is predicted to increase at a compound annual growth rate (CAGR) of 5.6 percent from 2021 to 2028, with a market value of USD 1.7 billion in 2020. One of the key factors driving the market for sternal closure systems is the growing geriatric population undergoing open-heart surgery using median sternotomy. Due to convenient and speedy access to heart valves and arteries, the median sternotomy method has remained the most frequent technique for cardiac exposure to date. Prior to and after heart surgery, sternotomy and sternal closure are performed.
The market for sternal closure systems is expanding due to an increase in the number of surgical procedures performed around the world. According to the OECD, surgical treatments in the United Kingdom were anticipated to be approximately 399,952 in 2012, rising to 491,604 in 2016.Furthermore, in the senior population, lack of activity and poor diet raise the risk of heart disease. In addition, the expanding senior population, which is more prone to chronic CVDs, is contributing to an increase in the number of cardiovascular surgical procedures, which is driving up demand for sternal closure systems around the world.
Furthermore, due to the rise in non-communicable disease burden and injuries, emerging countries are focusing on investing in public healthcare infrastructure. Surgical operations will also increase in developing regions. China's per capita healthcare expenditure in 2015 was USD 425.6, accounting for 5.3 percent of GDP, according to figures published by the World Bank. Furthermore, the Plan of Health China 2030 estimates that by 2020 healthcare spending is expected to account for 6.5% to 7% of its total GDP.
Furthermore, developing countries are focusing on investing in public healthcare infrastructure due to the rising non-communicable disease burden and injuries. This is projected to increase the number of surgical procedures in developing regions as well. According to data published by the World Bank, in 2015, China's per capita healthcare expenditure was USD 425.6, accounting for 5.3% of GDP Furthermore, according to China's Health 2030 Plan, healthcare spending will account for 6.5 percent to 7% of the country's total GDP by 2020. Sedentary lifestyles, excessive smoking and alcohol consumption, and a poor diet are all contributing to an increase in the prevalence of heart disorders around the world. This is leading to an increase in surgical operations, which will likely promote the adoption of sternal closure devices in the coming years. According to the Centers for Disease Control and Prevention, 28.1 million adults in the United States were diagnosed with heart disease in 2016.
Product Insights
In 2020, the closure devices category dominated the market for sternal closure systems, accounting for 71.5 percent of total revenue. The leading proportion of the market is attributed to reasons such as new launches combined with increased per capita expenditure in both developed and emerging economies. These devices have shown to have advantages such as a reduction in post-operative pain. In compared to bone cement, these devices have showed benefits such as a reduction in surgical problems and infections, as well as a speedier recovery period. Furthermore, prominent players in the market for sternal closure systems are increasing their efforts to create new techniques and product lines, which is expected to enhance the segment's growth in the near future.
Key products in this segment include Sterna Lock Blu and Sterna Lock 360 by Zimmer Biomet; Sternal ZIPFIX System by DePuy Synthes; and Sternal Talon Implants by KLS Martin Group. Companies in the sternal closure systems market are focused on R&D to provide advanced solutions. For example, Orthofix Holdings, Inc., a U.S.-based orthopedic product R&D and marketing company, invested USD 28.8 million in FY 2017 and USD 29.7 million in FY 2018, respectively. In January 2017, JACE Medical, LLC has launched pre-Monoblock sternal plates in the U.S. These plates are used prior to the surgery and work as implant positioner.
Material Insights
The titanium segment dominated the market for sternal closure systems in 2020, accounting for 42.9 percent of total sales. Titanium's dominance can be attributed to its corrosion resistance, ability to efficiently join human bones, and biocompatibility. Furthermore, titanium implants have a non-ferromagnetic characteristic that permits patients with titanium implants to be examined safely under Magnetic resonance imaging (MRI) scan, is further enhancing penetration of the material in the industry.
Furthermore, the high efficacy, non-toxic nature, and stability of titanium products, as well as increased economic feasibility and affordability for advanced titanium clips and plates in both developed and developing regions, are expected to boost the penetration of titanium-based sternal closure systems. Due to technical improvements, increased R&D spending by key players, and the material's biocompatible features, the Polyether Ether Ketone (PEEK) segment is predicted to grow at the fastest rate throughout the projection
Procedure Insights
The median sternotomies segment dominated the sternal closure systems market and accounted for the highest revenue share of 50.7% in 2020. The technique allows easy access to the heart, lungs, and surrounding structures during heart valve replacement surgery and coronary artery bypass surgery. Median sternotomies are often performed osteotomies around the world. In addition to reducing post-operative infections and problems, median sternotomies are becoming increasingly popular around the world.
The ageing population, which is more likely to acquire chronic cardiac problems including CVDs, is expected to drive demand for median sternotomy treatments. In the not-too-distant future, the global elderly population is expected to double. According to a report published by the United Nations Department of Economic and Social Affairs in 2015, the number of persons over the age of 60 is predicted to increase by 56.0 percent between 2015 to 2030. The geriatric population was 901 million in 2015 and anticipated to reach 2.1 billion by 2050.
Regional Insights
North America dominated the market for sternal closure systems in 2020, accounting for 35.0 percent of total revenue, and is likely to maintain its dominance during the forecast period. Increased collaboration efforts by key companies to strengthen their product offerings and ensure high-quality standards are expected to drive demand for systems in the region. A&E Medical Corporation, for example, purchased RTI Surgical Cardiothoracic Closure business in August 2017. The Cardiothoracic Closure division of RTI Surgical produces cable-based plate devices such the Tritium SPC System. Furthermore, North America's large share can be ascribed to the region's high prevalence of heart disease .According to a CDC research, approximately 28.1 million persons in the United States have been diagnosed with heart-related illnesses such as cardiac arrest and valvular heart disease. Furthermore, favorable reimbursement regulations are projected to boost the market for sternal closure systems even further . From 2018, sternal closure procedures are covered under MS-DRG codes 216, 217, 218, 219, 220, 221, 228, and 229, according to the new wound closure Medicare reimbursement coding guide.
Key Companies & Market Share Insights
The major methods used by market players to maintain their position in the sternal closure systems market include product launches, strategic acquisitions, and innovation. To broaden its product offering for degenerative spine conditions, Deputy Synthes launched CONDUIT interbody Platform with EIT cellular titanium technology in September 2019. In October of last year, Zimmer Biomet introduced Vitality+ and Vital Spinal Fixation Systems in the U.S. For degenerative thoracolumbar surgeries, the Vital Spinal Fixation System is a viable option. The following are some of the major participants in the sternal closure systems market:
Zimmer Biomet
Johnson & Johnson
B. Braun Melsungen AG
Orthofix Holdings, Inc.
GE Healthcare
KLS Martin Group
A&E Medical Corporation
Jace Medical, LLC
Acute Innovations
Abyrx, Inc.
Kinamed Incorporated
Comments
Post a Comment